Eton Pharmaceuticals, Inc.: cashflow_investing
| Value | {"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | Eton Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:30:35.976646+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8b7c295e-9182-470c-a6b2-e205d7f2f863
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-25-016475Retrieved: 2026-08-19T17:30:35.976646+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001710340/cashflow-investing/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8b7c295e-9182-470c-a6b2-e205d7f2f863
History
- no predecessors — first report